BCYC · Bicycle Therapeutics PLC · Documents

Oct 12

Registration statement S-3ASR

Registration statement

Oct 7

Current report 8-K

Other events

Aug 5

Current report 8-K

Financial results

Aug 5

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $1.79M ▲ 13.6% Net loss $17.91M Diluted EPS -$0.74

Jul 13

Current report 8-K Events of Jul 9

Entered into a material agreement, Unregistered sale of equity

Jun 28

Current report 8-K

Shareholder vote results

Jun 16

Proxy statement DEFA14A

Proxy statement

May 27

Proxy statement DEFA14A

Proxy statement

May 24

Current report 8-K

Other events

May 6

Current report 8-K

Financial results

May 6

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $1.81M ▲ 60.1% Net loss $16.19M

Apr 30

Proxy statement DEF 14A Meeting Jun 28, 2021

Proxy statement

Apr 19

Proxy statement PRE 14A Meeting Jun 28, 2021

Proxy statement

Apr 9

Current report 8-K Events of Apr 7

Director or officer change, or executive pay

Apr 2

Current report 8-K Events of Mar 30

Other events

Mar 19

Current report 8-K Events of Mar 17

Director or officer change, or executive pay

Mar 16

Current report 8-K

Regulation FD disclosure, Other events

Mar 11

Current report 8-K

Financial results

Mar 11

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $10.39M ▼ 24.7% Net loss $51.01M

Jan 14

Current report 8-K

Regulation FD disclosure, Other events

Nov 20

Current report 8-K

Entered into a material agreement, Other events

Nov 5

Current report 8-K

Financial results

Nov 5

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $3.84M ▲ 525.7% Net loss $10.14M

Oct 2

Current report 8-K

Other events

Oct 1

Current report 8-K Events of Sep 30

Entered into a material agreement, New debt or off-balance-sheet obligation

Aug 5

Current report 8-K

Financial results

Aug 5

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $1.57M ▲ 3.2% Net loss $12.12M

Jun 29

Current report 8-K

Shareholder vote results

Jun 5

Registration statement S-3

Registration statement

May 7

Current report 8-K

Financial results

May 7

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Revenue $1.13M ▼ 82.3% Net loss $11.32M

Apr 27

Proxy statement DEF 14A Meeting Jun 29, 2020

Proxy statement

Apr 7

Current report 8-K

Other events

Mar 10

Current report 8-K

Financial results

Mar 10

Annual report 10-K FY2019, ended Dec 31

Annual report for FY2019

Revenue $13.8M ▲ 93.4% Net loss $30.61M

Feb 28

Current report 8-K Events of Feb 18

Other events

Feb 25

Current report 8-K Events of Feb 21

Entered into a material agreement, Other events